Conditional deletion of the tumor suppressor Hic1 results in aneuploidy and single-step transformation

被引:0
|
作者
Szczepny, Anette [1 ]
McKenzie, Lisa [1 ]
Jayesekara, Samantha [1 ]
Russell, Prue [2 ]
Wright, Gavin [2 ]
Baylin, Stephen B. [3 ]
Rossello, Fernando J. [1 ]
Cain, Jason E. [1 ]
Watkins, David N. [4 ]
机构
[1] Monash Univ, Clayton, Vic, Australia
[2] St Vincents Hosp, Melbourne, Vic, Australia
[3] Kimmel Canc Ctr Johns Hopkins, Baltimore, MD USA
[4] St Vincents Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia
关键词
D O I
10.1158/1538-7445.AM2014-LB-81
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
LB-81
引用
收藏
页数:1
相关论文
共 41 条
  • [21] Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer
    Chen, Hong-Chang
    Huang, Hsuan-Yuan
    Chen, Yao-Li
    Lee, Kuan-Der
    Chu, Yi-Ru
    Lin, Ping-Yi
    Hsu, Chia-Chen
    Chu, Pei-Yi
    Huang, Tim H. -M.
    Hsiao, Shu-Huei
    Leu, Yu-Wei
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (02) : 578 - 585
  • [22] Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses
    Chen, WY
    Wang, DH
    Yen, RWC
    Luo, JY
    Gu, W
    Baylin, SB
    CELL, 2005, 123 (03) : 437 - 448
  • [23] Methylation of the Tumor Suppressor Genes HIC1 and RassF1A Clusters Independently From the Methylation of Polycomb Target Genes in Colon Cancer
    Hong-Chang Chen
    Hsuan-Yuan Huang
    Yao-Li Chen
    Kuan-Der Lee
    Yi-Ru Chu
    Ping-Yi Lin
    Chia-Chen Hsu
    Pei-Yi Chu
    Tim H.-M. Huang
    Shu-Huei Hsiao
    Yu-Wei Leu
    Annals of Surgical Oncology, 2017, 24 : 578 - 585
  • [24] Hypermethylated in Cancer 1 (HIC1), a Tumor Suppressor Gene Epigenetically Deregulated in Hyperparathyroid Tumors by Histone H3 Lysine Modification
    Svedlund, Jessica
    Edblom, Susanne Koskinen
    Marquez, Victor E.
    Akerstrom, Goran
    Bjorklund, Peyman
    Westin, Gunnar
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (07): : E1307 - E1315
  • [25] Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome
    Carter, MG
    Johns, MA
    Zeng, XB
    Zhou, L
    Zink, MC
    Mankowski, JL
    Donovan, DM
    Baylin, SB
    HUMAN MOLECULAR GENETICS, 2000, 9 (03) : 413 - 419
  • [26] An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved ψKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity
    Stankovic-Valentin, Nicolas
    Deltour, Sophie
    Seeler, Jacob
    Pinte, Sebastien
    Vergoten, Gerard
    Guerardel, Cateline
    Dejean, Anne
    Leprince, Dominique
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (07) : 2661 - 2675
  • [27] HIC1 Tumor Suppressor Loss Potentiates TLR2/NF-κB Signaling and Promotes Tissue Damage-Associated Tumorigenesis
    Janeckova, Lucie
    Pospichalova, Vendula
    Fafilek, Bohumil
    Vojtechova, Martina
    Tureckova, Jolana
    Dobes, Jan
    Dubuissez, Marion
    Leprince, Dominique
    Baloghova, Nikol
    Horazna, Monika
    Hlavata, Adela
    Stancikova, Jitka
    Sloncova, Eva
    Galuskova, Katerina
    Strnad, Hynek
    Korinek, Vladimir
    MOLECULAR CANCER RESEARCH, 2015, 13 (07) : 1139 - 1148
  • [28] Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
    Xueqing Sun
    Qing Qu
    Yimin Lao
    Mi Zhang
    Xiaoling Yin
    Huiqin Zhu
    Ying Wang
    Jie Yang
    Jing Yi
    Mingang Hao
    BMC Cancer, 19
  • [29] Physical and functional interaction of the proto-oncogene EVI1 and tumor suppressor gene HIC1 deregulates Bcl-xL mediated block in apoptosis
    Pradhan, Anjan Kumar
    Halder, Arundhati
    Chakraborty, Soumen
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 53 : 320 - 328
  • [30] Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
    Sun, Xueqing
    Qu, Qing
    Lao, Yimin
    Zhang, Mi
    Yin, Xiaoling
    Zhu, Huiqin
    Wang, Ying
    Yang, Jie
    Yi, Jing
    Hao, Mingang
    BMC CANCER, 2019, 19 (01)